View Older Stories View More Recent Stories

Apr 3, 2014 04:01PM AGTC Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Apr 3, 2014 09:02AM Catyalyst Pharma (CPRX) Prices 11.33M Common Offering at $2.21/Share

Apr 2, 2014 04:04PM Endocyte (ECYT) Closes 5.18M Offering; Sees Net Proceeds of $101.8M

Apr 2, 2014 04:01PM Endocyte, Inc. Closes Public Offering of Common Stock

Apr 2, 2014 08:45AM Roth Affirms Keryx (KERX) at 'Buy'; ESRD Overhang Removed

Apr 1, 2014 11:23AM Roth Lifts PT on Stemline (STML) to $62; Sees 'Pivotal' Year in 2014

Apr 1, 2014 09:50AM Roth Sees Regeneron/Sanofi Alirocumab Phase 2 Results as Positive; Maintains 'Buy' Rating (REGN)

Apr 1, 2014 08:40AM Clean Diesel (CDTI) Announces $6.9M Equity Raise

Apr 1, 2014 08:38AM CDTi to Raise Approximately $6.9 Million

Apr 1, 2014 07:47AM Roth Capital Positive on Palatin (PTN) Granting Bremelanotide Extension

Mar 31, 2014 01:59PM Roth Raises PT on Regeneron (REGN) to $382; ODYSSEY MONO, Alirocumab Data Bolsters Positive Outlook

Mar 31, 2014 01:49PM Regeneron Pharma (REGN) PT Raised to $382 at Roth Capital

Mar 31, 2014 08:39AM Roth Boosts PT on Curis (CRIS) to $10; '427 Overhang Now Lifted

Mar 28, 2014 02:05PM Notable 52-Week Highs and Lows of the Day 03/28: (AA) (ELY) (INVN) High; (EXEL) (SPEX) Low

Mar 28, 2014 11:24AM Notable Analyst Rating Changes 03/28: (SCTY) (CTSH) (INVN) Upgraded; (PNW) (CIEN) (PCG) Downgraded

Mar 28, 2014 09:22AM Cytokinetics (CYTK) Starts COSMIC-HF Phase II Enrollment; BENEFIT-ALS Still in Focus - Roth

Mar 28, 2014 07:17AM Endocyte (ECYT) Prices 4.5M Share Offering at $21

Mar 28, 2014 07:12AM Roth Capital Upgrades InvenSense (INVN) to Buy

Mar 27, 2014 06:48PM Endocyte, Inc. Prices Public Offering of Common Stock

Mar 27, 2014 10:50AM Cytokinetics' (CYTK) Initiation of CK-2127107 Phase I is Positive Development - Roth

Mar 27, 2014 10:27AM Applied Genetic Technologies (AGTC) IPO Opens Higher

Mar 27, 2014 10:21AM Alt-Energy Names Show Early Gains (FCEL)(BLDP) (PLUG)

Mar 27, 2014 10:07AM Roth Starts Active Power (ACPW) at Buy; Refocused Company Should See N-T Gains

Mar 27, 2014 08:17AM Applied Genetic Technologies (AGTC) IPO Prices at $12, Below Range

Mar 27, 2014 06:33AM Roth Capital Starts Active Power (ACPW) at Buy

Mar 26, 2014 06:56PM AGTC Announces Pricing of Initial Public Offering

Mar 26, 2014 12:29PM RGS Energy's (RGSE) New Financing Strategy Could Provide Upside; Roth Boosts PT to $6

Mar 26, 2014 08:17AM American Apparel (APP) Prices 61M Common Offering at 50c/Share

Mar 25, 2014 10:34AM Notable Analyst Rating Changes 03/25: (SOL) (RAX) (PCAR) Upgraded; (HIMX) (PHM) (ACI) Downgraded

Mar 25, 2014 09:27AM Pre-Open Stock Movers 3/25: (GALT) (ECYT) (RAX) Higher; (IDN) (HIMX) (GIII) Lower (more...)

Mar 25, 2014 08:53AM Roth Upgrades ReneSola (SOL) to Buy; Sees Outperformance Continuing on Strong Differentiation

Mar 25, 2014 08:34AM American Apparel (APP) Commences $30.5M Cmmon Stock Offering

Mar 25, 2014 07:55AM Roth Capital Upgrades Silvercrest Mines (SVLC) to Buy

Mar 25, 2014 06:57AM Roth Capital Upgrades ReneSola Ltd. (SOL) to Buy

Mar 24, 2014 02:56PM Stronger-than-Expected FY13 Results Set Rexahn Pharma (RNN) Up for Promising FY14 - Analyst

Mar 24, 2014 07:46AM Roth Cuts PT on Curis (CRIS) to $9; Erivedge Phase 2 Misses Roche's (RHHBY) Internal Expectations

Mar 21, 2014 07:08AM Palatin Technologies (PTN) is Ready to Soar; Roth Reaffirms 'Buy' Rating

Mar 20, 2014 11:08AM Synta Pharma (SNTA) Positive Trajectory Reinforced by Latest ENCHANT-1 Data - Roth

Mar 20, 2014 09:31AM Roth on Sidelines with Yingli Green Energy (YGE); Leverage Will Continue to Limit Upside

Mar 20, 2014 08:32AM Applied Optoelectronics (AAOI) Prices 3M Common Follow-On at $24.25/Share

Mar 20, 2014 08:30AM Applied Optoelectronics Announces Pricing of Follow-on Public Offering

Mar 19, 2014 09:14AM Roth Capital Starts Concert Pharmaceuticals (CNCE) at Buy

Mar 19, 2014 08:57AM Roth Lifts PT on SolarCity (SCTY) to $80; Notes GAAP Measures are Often Underestimated

Mar 18, 2014 02:50PM Roth Still Bullish on Ligand Pharma (LGND) Following NOXAFIL Approval (MRK)

Mar 18, 2014 07:35AM Roth Cuts PT on Galena Biopharma (GALE) on SEC Risk

Mar 14, 2014 02:14PM Roth Reaffirms Peregrine Pharma (PPHM) at Buy; Prelim. Bavituximab + Sorafenib Phase I/II is Positive

Mar 14, 2014 12:23PM Roth Keeps ImmunoCellular (IMUC) at Neutral; Sidelined Until ICT-107 Picture Clears

Mar 14, 2014 10:37AM Notable Analyst Rating Changes 03/14: (TEVA) (SIRI) (LOW) Upgraded; (PLUG) (XOXO) (NUE) Downgraded

Mar 14, 2014 10:17AM Roth Keeps Keryx Biopharma (KERX) at Buy; Zerenex Potential Remains Strong

Mar 14, 2014 09:30AM Pre-Open Stock Movers 3/14: (HART) (MEET) (LMCA) Higher; (ARO) (ZBB) (PLUG) Lower (more...)

View More Recent Stories View Older Stories